Skip to main content

Advertisement

Table 1 Summary of Demographic Data and Disease Characteristics at Baseline (all randomized subjects)

From: 24-hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitis [ISRCTN32042139]

    Desloratadine    
Characteristic 2.5 mg (n = 173) 5 mg (n = 172) 7.5 mg (n = 173) 10 mg (n = 172) 20 mg (n = 172) Placebo (n = 174)
Mean (range) age, years 34 (13–73) 34 (12–75) 34 (12–73) 34 (12–70) 34 (12–72) 35 (12–63)
Age group, years       
   12–17 22 26 25 28 25 22
   18–65 150 143 145 143 145 152
   >65 1 3 3 1 2 0
Sex       
   Male 73 68 68 71 62 81
   Female 100 104 105 101 110 93
Mean duration (range) of seasonal allergic rhinitis, years 18 (2–60) 18 (2–55) 16 (2–50) 17 (2–49) 16 (2–48) 17 (2–50)